New pharmaceutical active compounds
申请公布号:US2001025043(A1)
申请号:US20010865231
申请日期:2001.05.25
申请公布日期:2001.09.27
发明人:BERGSTRAND HAKAN;KARABELAS KOSTAS;SJO PETER
分类号:C07D403/04;C07D405/14;C07D471/04;C07D475/00;C07D475/02;C07H19/04;(IPC1-7):A61K31/498
主分类号:C07D403/04
摘要:The present invention provides optionally substituted and/or annulated compounds of formula (I) wherein X, Y, Z and A is each independently carbon or nitrogen, and at least two of X, Y, Z and A are carbon; and pharmaceutically acceptable salts thereof with the proviso that: 3-(1H-Indol-3-yl)-1H-quinoxalin-2-one, 3-(2-Methyl-1H-indol-3-yl)-1H-quinoxalin-2-one, and 3-(1,2-Diphenyl-1H-indol-3-yl)-1H-quinoxalin-2-one are excluded from compounds of formula (I). The invention includes the use of compounds of formula (I) in medical therapy, particularly in the therapy of conditions requiring inhibition of protein kinase C.
LENS POSITION CONTROLLER FOR ZOOM LENS
WATERPROOF OPTICAL FIBER CABLE
METHOD AND DEVICE USED FOR DETERMINING AMINO ACID ARRAY
METHOD FOR DETERMINING SOLID SOLUTION MANGANESE IN ALUMINUM SAMPLE
FORMATION OF OPTICAL REFLECTING FILM
REPAIR WELDING EXECUTION FOR NEUTRON IRRADIATION MEMBER
METHOD FOR MEASURING LOW-TEMPERATURE CHARACTERISTICS OF LIGHT OIL